Cadila gets USFDA nod for Metformin

Cadila Healthcare has received further approval from USFDA for Metformin Hydrochloride ER tablet 750 mg.

On approval of the aforesaid product from USFDA, the company's ANDAs with respect to Metformin are approved, Cadila Healthcare said in a release issued to the BSE.